- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01678612
Efficacy of Copper in Reducing Health-Acquired Infections in a Pediatric Intensive Care Unit
April 9, 2014 updated by: Codelco
Efficacy of Copper in Reducing Health-Acquired Infections and Microbial Burden as Measured on High Touch Surfaces in a Pediatric Intensive Care Unit. A Controlled Clinical Trial.
Healthcare-acquired infections (HAI) cause substantial patient morbidity and mortality.
Commonly touched items in the patient care environment harbor microorganisms that may contribute to HAI risk.
The purpose of this study is to assess whether placement of copper-alloy surfaced objects in a pediatric intensive care unit (PICU) reduce risk of HAI in comparison with non-copper surfaced objects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1012
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Santiago, Chile
- Hospital Roberto del Rio
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 week to 15 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patient admitted to PICU
- stay at PICU > 24 hours
- informed consent by parent/legal representative
Exclusion criteria: none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Non copper standard surfaced objects
Rooms assigned to standard surfaced objects
|
|
Experimental: Copper-alloy surfaced objects
Rooms furnished with copper surfaced objects, i.e. bed rails, bed rail levers, IV poles, nurse workstation, clipboards, sink handles.
|
Room assigned to the Experimental arm will be furnished with copper-alloy surfaced objects,i.e.
bed-rails, bed-rail levers, IV poles, nurse workstation, HCW clipboards, sink handles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Hospital-Acquired Infections (HAI) incidence density / 1,000 patient-days
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 6 days
|
Participants will be followed for the duration of hospital stay, an expected average of 6 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Microbial Burden measured on high-touch copper and non-copper surfaced objects
Time Frame: 1 year study duration
|
Total microbial burden and selected bacteria (MRSA,VRE) will be measured twice a month in all bedrails and sink handles of the PICU study site.
|
1 year study duration
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of new events of colonization with selected pathogens per 1000 patient-days at risk
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 6 days
|
Patients with negative culture (from skin and mucosa samples) will be sampled at Day 3, Day 6 and discharge.
|
participants will be followed for the duration of hospital stay, an expected average of 6 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bettina von Dessauer, MD, Hospital Roberto del Rio
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
August 25, 2012
First Submitted That Met QC Criteria
August 30, 2012
First Posted (Estimate)
September 5, 2012
Study Record Updates
Last Update Posted (Estimate)
April 10, 2014
Last Update Submitted That Met QC Criteria
April 9, 2014
Last Verified
April 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CODEHRdR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nosocomial Infections
-
St. Luke's-Roosevelt Hospital CenterCompletedNosocomial InfectionsUnited States
-
Sohag UniversityUnknown
-
China Medical University HospitalUnknown
-
St. Luke's-Roosevelt Hospital CenterCompletedNosocomial InfectionsUnited States
-
Dartmouth-Hitchcock Medical CenterHarbor Medical Inc.CompletedNosocomial InfectionsUnited States
-
Children's Hospital of Fudan UniversityChina Medical BoardCompletedNosocomial InfectionsChina
-
Rennes University HospitalMinistry of Health, FranceCompletedNosocomial Infections | MRSA ColonizationFrance
-
Johns Hopkins UniversitySage Products, Inc.CompletedNosocomial InfectionsUnited States
-
Rabin Medical CenterCompletedNosocomial Infections | Community-associated Infections | Health-care Acquired InfectionsIsrael
-
University Hospital, LilleCompletedRespiratory Tract Diseases | Nosocomial InfectionsFrance
Clinical Trials on Copper-alloy surfaced objects
-
Medical University of South CarolinaMemorial Sloan Kettering Cancer Center; Ralph H. Johnson VA Medical CenterCompletedHealthcare-acquired InfectionUnited States